RECEIVABLES

12 Months Ended

Dec. 31, 2012

Receivables [Abstract]

Receivables [Text Block]

Note 10. RECEIVABLES

Receivables include:

	December 31,
Dollars in Millions	2012		2011
Trade receivables	$	1,812	$	2,397
Less allowances		(104)		(147)
Net trade receivables		1,708		2,250
Alliance partners receivables		857		1,081
Prepaid and refundable income taxes		319		256
Miscellaneous receivables		199		156
Receivables	$	3,083	$	3,743

Receivables are netted with deferred income related to alliance partners until recognition of income. As a result, alliance partner receivables and deferred income were reduced by $1,056million and $901million at December 31, 2012 and 2011, respectively. For additional information regarding alliance partners, see “—Note 3. Alliances and Collaborations.” Non-U.S. receivables sold on a nonrecourse basis were $956 million in 2012, $1,077 million in2011, and $932 million in 2010. In the aggregate, receivables from three pharmaceutical wholesalers in the U.S. represented 37% and 55% of total trade receivables at December 31, 2012 and 2011, respectively.

Changes to the allowancesfor bad debt, charge-backs and cash discounts were as follows:

	Year Ended December 31,
Dollars in Millions	2012		2011		2010
Balance at beginning of year	$	147	$	107	$	103
Provision		832		1,094		864
Utilization		(875)		(1,054)		(860)
Balance at end of year	$	104	$	147	$	107